Department of Pathology, University of Maryland Medical Center, Baltimore, MD, USA.
Am J Surg Pathol. 2012 Feb;36(2):273-82. doi: 10.1097/PAS.0b013e31823b3eeb.
Recently, a new classification of lung adenocarcinomas has been proposed for tumors with lepidic spread. The greatest diameter of the invasive component determines minimally invasive cancers, and the term bronchioloalveolar carcinoma is no longer used.
We retrospectively reviewed 87 resected adenocarcinomas of the lung; 30 tumors with lepidic growth and without high-grade invasive areas were identified, and the invasive component was measured morphometrically and categorized. A dimension of 5 mm was the cutoff for invasion. Regional lymph node involvement and short-term follow-up were compared among subtypes of these well-differentiated and moderately differentiated adenocarcinomas.
There were 11 well-differentiated adenocarcinomas with lepidic growth: 3 adenocarcinomas in situ (nonmucinous) and 8 minimally invasive adenocarcinomas (MIAs) (4 mucinous and 4 nonmucinous). There were 19 invasive moderately differentiated adenocarcinomas with a prominent lepidic growth pattern (LPAs). The mean size of the 3 adenocarcinomas in situ cases was 0.9±0.7 mm; the total size of the 8 MIA cases was 1.4±1.8 cm and that of the 19 LPA cases was 3.2±2.1 cm. The invasive size of the MIA was 0.3±0.6 and that of the LPA was 2.2±0.3. The invasive pattern of the LPAs was papillary and acinar without desmoplasia (n=3) and acinar with desmoplasia (n=16). Seven of the invasive desmoplastic tumors showed complex single-cell invasion or lymphatic invasion. Identification of the transition from lepidic to invasive acinar was straightforward because of the presence of elastotic desmoplasia. The transition between complex acinar papillary invasion and lepidic growth was often difficult to discern. Lymph node metastases were present in 5 cases (26%), all in tumors with an acinar, desmoplastic invasive component of >1 cm, with areas of single-cell invasion. With follow-up, progressive nodal involvement or distant metastases occurred in 4 patients, all with complex invasive patterns; 3 with invasion >1 cm and 1 with lymphatic invasion in smaller invasive tumors. Recurrent lung nodules occurred in 5 patients, including 1 patient with MIA, 1 with nondesmoplastic invasion, 2 with desmoplastic invasion, and 1 with complex desmoplastic invasion.
Approximately one third of lung adenocarcinomas have significant lepidic spread, and of these nearly one third are minimally invasive. Measurement of the invasive component may be difficult without elastotic desmoplasia. In this small series, lymph node and distant metastases occurred only in those with complex invasive patterns, but lung recurrence occurred in all subtypes, including MIAs.
最近,提出了一种新的肺腺癌分类,用于具有贴壁生长的肿瘤。侵袭成分的最大直径决定了微侵袭性癌症,并且不再使用细支气管肺泡癌这一术语。
我们回顾性分析了 87 例肺腺癌切除术标本;确定了 30 例具有贴壁生长且无高级别侵袭区域的肿瘤,并通过形态计量学测量和分类来评估侵袭成分。侵袭的临界值为 5mm。比较这些分化良好和中度分化腺癌亚型的区域淋巴结受累和短期随访情况。
有 11 例分化良好的贴壁生长腺癌:3 例原位腺癌(非黏液性)和 8 例微侵袭性腺癌(MIA)(4 例黏液性和 4 例非黏液性)。有 19 例侵袭性中分化腺癌具有明显的贴壁生长模式(LPAs)。3 例原位腺癌病例的平均大小为 0.9±0.7mm;8 例 MIA 病例的总大小为 1.4±1.8cm,19 例 LPA 病例的大小为 3.2±2.1cm。MIA 的侵袭大小为 0.3±0.6cm,LPA 的侵袭大小为 2.2±0.3cm。LPA 的侵袭模式为无纤维增生的乳头状和腺泡状(n=3)和有纤维增生的腺泡状(n=16)。7 例侵袭性纤维增生性肿瘤表现为复杂的单细胞浸润或淋巴管浸润。由于存在弹性纤维增生,很容易识别贴壁向侵袭性腺泡的转变。复杂的腺泡状乳头状浸润与贴壁生长之间的转变通常难以辨别。5 例(26%)患者存在淋巴结转移,均存在>1cm、有单细胞浸润的腺泡状、纤维增生性侵袭性成分的肿瘤。随访时,4 例(21%)患者出现进行性淋巴结或远处转移,均为侵袭模式复杂的患者;3 例侵袭性肿瘤>1cm,1 例较小侵袭性肿瘤有淋巴管浸润。5 例患者出现复发性肺结节,包括 1 例 MIA、1 例无纤维增生性浸润、2 例纤维增生性浸润和 1 例复杂纤维增生性浸润。
约三分之一的肺腺癌有明显的贴壁生长,其中近三分之一为微侵袭性。如果没有弹性纤维增生,侵袭成分的测量可能会很困难。在本小系列中,只有复杂侵袭模式的患者才会出现淋巴结和远处转移,但所有亚型(包括 MIA)都有肺部复发。